GC Aesthetics, Inc. (GCA), a privately held medical technology company providing healthcare aesthetic solutions, has launched FixNip™ NRI, a nipple areola complex (NAC) reconstruction implant, in certain European markets. The company will launch the product in Latin America and Asia later this year.

“We are committed to deliver safe options that establish a newer, higher, and more beneficial standard of care for women who seek to total breast reconstruction,” says Carlos Reis Pinto, CEO of GC Aesthetics. “Such technology breakthrough will complete our range of solutions dedicated to women aesthetic healthcare. FixNip by GC Aesthetics is a healthcare game-changer.”

A plastic surgeon implants the GC Aesthetics FixNip NRI via a minimally invasive procedure that takes 15 minutes, on average. GC Aesthetics officials say the results have been positive, demonstrating high patient satisfaction with a minimum patient. The safety profile has also been excellent, they say. 

“The NAC reconstruction procedure should be considered an integral part of the breast reconstructive surgery,” says French plastic surgeon Michael Atlan, MD, PhD. It gives women an important psychological contribution and leads a greater well-being, overall sense of self and high satisfaction after being reconstructed. As a leader of the GCA multi-centric safety and efficacy trial, I am highly satisfied with the results.”